03NSW HEALTH HEPATITIS B STRATEGY 2014-2020 Despite being a vaccine preventable disease, hepatitis B is a substantial public health problem in Australia and internationally. It is a major cause of liver disease, including liver cancer, and drives much of the demand for liver transplantation.In NSW, about 77,000 people are living with hepatitis B, many of whom are not aware that they have the infection. Hepatitis B is disproportionately common among people originating from high prevalence countries and Aboriginal people, and this pattern of infection has implications for the public health response to hepatitis B in NSW.In recent years in NSW, we have experienced success in preventing locally acquired hepatitis B infections, and our public health professionals are rightly proud of the reach and effectiveness of established hepatitis B vaccination programs, in particular the universal infant hepatitis B vaccination program. Additionally, over many decades our specialist services have made an enormous contribution to the health of individuals and populations through the provision of high quality clinical care.Nevertheless, more work is required to reduce the impact of hepatitis B in NSW. We need to reduce current levels of hepatitis B transmission, reduce the pool of undiagnosed infections, and do more to ensure that people with chronic hepatitis B are engaging with health services, so that their infection can be regularly monitored and effectively managed.Our priorities for action are clear. We will build on existing strategies to prevent the transmission of hepatitis B in NSW and make it easier for people at risk of hepatitis B to get tested. We will support people who are newly diagnosed into a pathway of care and support general practitioners and other primary health care professionals to play a larger role in monitoring, managing and treating hepatitis B. And, we will help people with chronic infection to effectively manage their condition. Underpinning these actions is a focus on effective coordination of services and programs to ensure continuity of care for patients.We have set five Targets to be achieved by 2020.
ACTIONS SYSTEM ENABLERS• Surveillance• Performance monitoring and evaluation• Clinical redesign and innovation• Health systems and policy relevant research• Workforce development• Cultural competence• Community engagement and partnerships
• Effective governance• An evidence-informed population health approach
PRIORITY POPULATIONS• People living with hepatitis B • STRATEGY 2014STRATEGY -2020 Addressing the burden of chronic hepatitis B in NSW requires a preemptive strategy for the provision of care, focusing in particular on improving diagnosis and management of hepatitis B infections. In NSW, established antenatal screening for hepatitis B provides an opportunity for early detection and intervention in pregnant women and their infants. Diagnosis during pregnancy also provides opportunities to promote testing and vaccination among family and household contacts and to initiate ongoing care to prev...